Using whole-exome sequencing methods, the aforementioned study described mutations in PTEN, RB1, TP53, and CDH1. Despite the use of a very small number of ESS samples in this study (3 LG-ESS), it is a valuable contribution to the understanding of the pathogenesis of such tumors. This evidence concerns the gene CDH1 and endometrioid stromal sarcoma.